Left ventricular systolic dysfunction: A sudden killer in end-stage renal disease patients

Hypertension

Volumn 56, Issue 2, 2010, Pages 187-188

  Zoccali, Carmine ^a  

^a BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROMYCIN; FETUIN A; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PHOSPHATE; POTASSIUM CHANNEL; SOTALOL; TROPONIN T;

ARRHYTHMOGENESIS; ARTERIAL STIFFNESS; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR DISEASE; DEFIBRILLATOR; DIABETES MELLITUS; ECHOCARDIOGRAPHY; EDITORIAL; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE SYSTOLIC DYSFUNCTION; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HEMODIALYSIS; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LONG QT SYNDROME; MORTALITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; POLYMORPHIC VENTRICULAR TACHYCARDIA; PREDICTION; PRIMARY PREVENTION; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROTEIN BLOOD LEVEL; RENAL REPLACEMENT THERAPY; RISK FACTOR; SECONDARY PREVENTION; SUDDEN DEATH; SURVIVAL; SYMPATHETIC TONE; SYSTOLIC DYSFUNCTION; UREMIA; CHRONIC KIDNEY FAILURE; HEART LEFT VENTRICLE FUNCTION; NOTE; RISK ASSESSMENT; SYSTOLE; TREATMENT OUTCOME;

CARDIOVASCULAR DISEASES; DEATH, SUDDEN, CARDIAC; HUMANS; KIDNEY FAILURE, CHRONIC; PROBABILITY; RISK ASSESSMENT; SYSTOLE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77955500550     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.151829     Document Type: Editorial

References (10)

1. De Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, Collart F, Finne P, Heaf JG, De MJ, Wetzels JF, Rosendaal FR, Dekker FW. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009;302:1782-1789.
2. Herzog CA. Cardiac arrest in dialysis patients: approaches to alter an abysmal outcome. Kidney Int. 2003;84(suppl):S197-S200.
3. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, Seminara G, Stancanelli B, Malatino LS. Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol. 2001;12:2768-2774.
4. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, Seminara G, Stancanelli B, Malatino LS. Prognostic value of echo-cardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients. J Am Soc Nephrol. 2004;15:1029-1037.
5. Gussak I, Gussak HM. Sudden cardiac death in nephrology: focus on acquired long QT syndrome. Nephrol Dial Transplant. 2007;22:12-14.
6. Sforzini S, Latini R, Mingardi G, Vincenti A, Redaelli B. Ventricular arrhythmias and four-year mortality in haemodialysis patients: Gruppo Emodialisi e Patologie Cardiovascolari. Lancet. 1992;339:212-213.
7. Zoccali C, Mallamaci F, Tripepi G. Nocturnal hypoxemia predicts incident cardiovascular complications in dialysis patients. J Am Soc Nephrol. 2002;13:729-733.
8. Wang AY-M, Lam CW-K, Chan IH-S, Wang M, Lui S-F, Sanderson JE. Sudden cardiac death in end-stage renal disease patients: a 5-year prospective analysis. Hypertension. 2010;56:210-216.
9. Cice G, Tagliamonte E, Ferrara L, Iacono A. Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study. Eur Heart J. 2000;21:1259-1264.
10. Herzog CA, Li S, Weinhandl ED, Strief JW, Collins AJ, Gilbertson DT. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int. 2005;68:818-825.